Ubs Asset Management Americas Inc Abbott Laboratories Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 9,233,933 shares of ABT stock, worth $1.05 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares

9,233,933

Previous 9,811,210 5.88%

Holding current value

$1.05 Billion

Previous $1.02 Billion 3.26%

% of portfolio

0.28%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $57.8 Million - $68.2 Million	-577,277 Reduced 5.88%	9,233,933 $1.05 Billion
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $287 Million - $320 Million	2,848,172 Added 40.9%	9,811,210 $1.02 Billion
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $6.79 Million - $7.5 Million	-62,034 Reduced 0.88%	6,963,038 $791 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $33.4 Million - $40.9 Million	-370,609 Reduced 5.01%	7,025,072 $773 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $946 Million - $1.14 Billion	-9,902,729 Reduced 57.25%	7,395,681 $716 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $871 Million - $1.03 Billion	8,995,652 Added 108.35%	17,298,410 $1.75 Billion
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $86.3 Million - $101 Million	908,048 Added 12.28%	8,302,758 $912 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $19.8 Million - $23 Million	-205,115 Reduced 2.7%	7,394,710 $716 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $53.2 Million - $64.3 Million	521,341 Added 7.37%	7,599,825 $826 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $11.8 Million - $14.4 Million	-103,844 Reduced 1.45%	7,078,484 $838 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $156 Million - $191 Million	-1,348,358 Reduced 15.81%	7,182,328 $1.01 Billion
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $99.7 Million - $110 Million	854,744 Added 11.14%	8,530,686 $1.01 Billion
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $120 Million - $141 Million	-1,134,092 Reduced 12.87%	7,675,942 $890 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $44 Million - $51.9 Million	-404,423 Reduced 4.39%	8,810,034 $1.06 Billion
Q4 2020 Mar 01, 2021	BUY	$105.0 - $114.42 $74.2 Million - $80.9 Million	706,896 Added 8.31%	9,214,457 $1.01 Billion
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $11.2 Million - $13.6 Million	121,985 Added 1.45%	8,507,561 $926 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $222 Million - $285 Million	-2,903,886 Reduced 25.72%	8,385,576 $767 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $92.4 Million - $135 Million	1,471,198 Added 14.98%	11,289,462 $891 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $51.1 Million - $56.9 Million	-651,067 Reduced 6.22%	9,818,264 $853 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $46.5 Million - $50.4 Million	567,697 Added 5.73%	10,469,331 $876 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $54.1 Million - $63.1 Million	-742,604 Reduced 6.98%	9,901,634 $0
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $26.1 Million - $31.6 Million	394,774 Added 3.85%	10,644,238 $0
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $122 Million - $138 Million	1,854,616 Added 22.09%	10,249,464 $741 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $9.08 Million - $11 Million	-149,338 Reduced 1.75%	8,394,848 $0
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $26 Million - $28.7 Million	451,554 Added 5.58%	8,544,186 $0
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $38.3 Million - $43.4 Million	681,392 Added 9.19%	8,092,632 $0
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $40.3 Million - $43.2 Million	-751,008 Reduced 9.2%	7,411,240 $0
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $392 Million - $438 Million	8,162,248	8,162,248 $0

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Abbott Laboratories Transaction History